Intro

This chapter explores the recent breakthroughs in understanding Parkinson's disease, emphasizing the role of synuclein-based biomarkers for diagnosis and treatment. It highlights the shift towards skin-based assays, the development of imaging biomarkers, and the biological classification of the disease.